Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Alamar Biosciences, Inc.
ALMR ยท SEC Filings
website
222
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensit...
Price
31.84
Market Cap
2.21 B
Float
35.83 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about ALMR
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Alamar Biosciences, Inc.
ALMR ยท SEC Filings
35.83 M
Float
31.84
Price
2.21 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 3, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 8, 2026
News
TYPE
HEADLINE
FILED AT
8-K
Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Nov 3, 2026
8-K
Alamar Biosciences, Inc. Appoints Robert Ragusa to Board of Directors
Sep 1, 2026
8-K
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
Aug 10, 2026
8-K
Alamar Biosciences, Inc. Announces Passing of Board Member Ian Ratcliffe
Jul 15, 2026
8-K
Alamar Biosciences Reports First Quarter 2026 Financial Results and Recent IPO Completion
May 8, 2026
8-K
Alamar Biosciences, Inc. Completes Initial Public Offering
Apr 20, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B4
IPO | Offering amount: $191,250,000 | Shares: 11,250,000 | Price: $17.000 | Bank: J.P. Morgan
Apr 17, 2026
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 20, 2026
POS AM
Form POS AM - Post-Effective amendments for registration statement
Apr 20, 2026
S-1MEF
OFFERING - Firm Commitment
Apr 16, 2026
S-1/A
OFFERING - IPO | Bank: J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners, Stifel
Apr 16, 2026
8-A12B
Form 8-A12B - Registration of securities [Section 12(b)]
Apr 15, 2026
S-1/A
OFFERING - IPO | Bank: J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners, Stifel
Apr 13, 2026
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
4
Qiming Venture Partners VI, L.P. (Reporting)
Nov 5, 2026
4
Qiming Venture Partners VI, L.P. (Reporting)
Nov 3, 2026
4
Qiming Venture Partners VI, L.P. (Reporting)
Oct 29, 2026
4
Qiming Venture Partners VI, L.P. (Reporting)
Oct 27, 2026
4
Qiming Venture Partners VI, L.P. (Reporting)
Oct 23, 2026
4
Qiming Venture Partners VI, L.P. (Reporting)
Oct 21, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 21, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 17, 2026